학술논문
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
Document Type
Article
Author
Source
In: Frontiers in Immunology . (Frontiers in Immunology, 2024, 15)
Subject
Language
English
ISSN
16643224